loadpatents
name:-0.072781085968018
name:-0.065058946609497
name:-0.0090508460998535
Sauerberg; Per Patent Filings

Sauerberg; Per

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sauerberg; Per.The latest application filed is for "glucose sensitive insulin derivatives".

Company Profile
8.66.71
  • Sauerberg; Per - Farum DK
  • Sauerberg; Per - Valby DK
  • Sauerberg; Per - Sondervangsalle DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
Grant 11,420,929 - Sauerberg , et al. August 23, 2
2022-08-23
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
Grant 11,382,957 - Sauerberg , et al. July 12, 2
2022-07-12
Glucose Sensitive Insulin Derivatives
App 20220184184 - Hoeg-Jensen; Thomas ;   et al.
2022-06-16
Glucose-sensitive Albumin-binding Derivatives
App 20220081451 - Kruse; Thomas ;   et al.
2022-03-17
Pharmaceutical Composition for Oral GLP-1 Administration Comprising a Tablet Core and Immediate Release Coating
App 20220062184 - Nybo; Pernille ;   et al.
2022-03-03
Glucose Sensitive Insulins And Uses Thereof
App 20220047708 - Hoeg-Jensen; Thomas ;   et al.
2022-02-17
Glucose-sensitive albumin-binding derivatives
Grant 11,186,595 - Kruse , et al. November 30, 2
2021-11-30
Tablet Formulation Comprising A Glp-1 Peptide And A Delivery Agent
App 20210275458 - Bjerregaard; Simon ;   et al.
2021-09-09
Phenoxy Acetic Acids And Phenyl Propionic Acids As Ppar Delta Agonists
App 20210188758 - SAUERBERG; Per ;   et al.
2021-06-24
Solid Compositions Comprising A Glp-1 Agonist And A Salt Of N-(8-(2-hydroxybenzoyl)amino)caprylic Acid
App 20210177944 - Sauerberg; Per ;   et al.
2021-06-17
Tablet formulation comprising a GLP-1 peptide and a delivery agent
Grant 11,033,499 - Jensen , et al. June 15, 2
2021-06-15
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid
Grant 10,960,052 - Sauerberg , et al. March 30, 2
2021-03-30
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
Grant 10,947,180 - Sauerberg , et al. March 16, 2
2021-03-16
Glucose-sensitive Albumin-binding Derivatives
App 20200325160 - Kruse; Thomas ;   et al.
2020-10-15
Phenoxy Acetic Acids And Phenyl Propionic Acids As Ppar Delta Agonists
App 20200215073 - SAUERBERG; Per ;   et al.
2020-07-09
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
Grant 10,471,066 - Sauerberg , et al. Nov
2019-11-12
Oral Dosing of GLP-1 Compounds
App 20190216739 - Nielsen; Flemming S. ;   et al.
2019-07-18
Oral dosing of GLP-1 compounds
Grant 10,278,923 - Nielsen , et al.
2019-05-07
GLP-1 derivatives, and uses thereof
Grant 10,266,577 - Sauerberg , et al.
2019-04-23
GLP-1 derivatives and uses thereof
Grant 10,195,255 - Reedtz-Runge , et al. Fe
2019-02-05
Solid Compositions Comprising A Glp-1 Agonist And A Salt Of N-(8-(2-hydroxybenzoyl) Amino) Caprylic Acid
App 20180360918 - Sauerberg; Per ;   et al.
2018-12-20
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
Grant 10,086,047 - Sauerberg , et al. October 2, 2
2018-10-02
Pharmaceutical Composition for Oral GLP-1 Administration Comprising a Tablet Core and Immediate Release Coating
App 20180263915 - Nybo; Pernille ;   et al.
2018-09-20
Tablet Formulation Comprising Semaglutide And A Delivery Agent
App 20180235888 - Jensen; Simon Bjerregaard ;   et al.
2018-08-23
Tablet formulation comprising semaglutide and a delivery agent
Grant 9,993,430 - Jensen , et al. June 12, 2
2018-06-12
Phenoxy Acetic Acids and Phenyl Propionic Acids as PPAR Delta Agonists
App 20180071304 - Sauerberg; Per ;   et al.
2018-03-15
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
Grant 9,855,274 - Sauerberg , et al. January 2, 2
2018-01-02
GLP-1 Derivatives and Uses Thereof
App 20170320927 - SAUERBERG; Per ;   et al.
2017-11-09
Oral Dosing of GLP-1 Compounds
App 20170312225 - Nielsen; Flemming S. ;   et al.
2017-11-02
Phenoxy Acetic Acids And Phenyl Propionic Acids As Ppar Delta Agonists
App 20170216303 - Sauerberg; Per ;   et al.
2017-08-03
Double-acylated GLP-1 derivatives
Grant 9,708,383 - Madsen , et al. July 18, 2
2017-07-18
Phenoxy acetic acids and phenyl propionic acids as PPAR.delta. agonists
Grant 9,663,481 - Sauerberg , et al. May 30, 2
2017-05-30
Derivatives of GLP-1 Like Peptides, and Uses Thereof
App 20170007707 - Reedtz-Runge; Steffen ;   et al.
2017-01-12
Derivatives of GLP-1 like peptides, and uses thereof
Grant 9,498,534 - Reedtz-Runge , et al. November 22, 2
2016-11-22
GLP-1 Derivatives, and Uses Thereof
App 20160200791 - Sauerberg; Per ;   et al.
2016-07-14
Solid Compositions Comprising A Glp-1 Agonist And A Salt Of N-(8-(2-hydroxybenzoyl)amino)caprylic Acid
App 20160151462 - Sauerberg; Per ;   et al.
2016-06-02
GLP-1 Derivatives and Uses Thereof
App 20160143998 - Reedtz-Runge; Steffen ;   et al.
2016-05-26
Oral Dosing of GLP-1 Compounds
App 20160067184 - Nielsen; Flemming S. ;   et al.
2016-03-10
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
Grant 9,278,123 - Sauerberg , et al. March 8, 2
2016-03-08
Tablet Formulation Comprising A Peptide And A Delivery Agent
App 20150150811 - Jensen; Simon Bjerregaard ;   et al.
2015-06-04
Derivatives Of Glp-1 Like Peptides, And Uses Thereof
App 20150011462 - Reedtz-Runge; Steffen ;   et al.
2015-01-08
Double-acylated Glp-1 Derivatives
App 20140179899 - Garibay; Patrick William ;   et al.
2014-06-26
Double-acylated GLP-1 derivatives
Grant 8,648,041 - Garibay , et al. February 11, 2
2014-02-11
Phenoxy Acetic Acids And Phenyl Propionic Acids As Ppar Delta Agonists
App 20140024645 - Sauerberg; Per ;   et al.
2014-01-23
Solid Compositions Comprising A Glp-1 Agonist And A Salt Of N-(8-(2-hydroxybenzoyl)amino)caprylic Acid
App 20130345134 - Sauerberg; Per ;   et al.
2013-12-26
Double-Acylated GLP-1 Derivatives
App 20130288960 - Madsen; Alice Ravn ;   et al.
2013-10-31
Phenoxy acetic acids as PPAR delta activators
Grant 8,551,993 - Sauerberg , et al. October 8, 2
2013-10-08
Phenoxy Acetic Acids As Ppar Delta Activators
App 20130102610 - Sauerberg; Per ;   et al.
2013-04-25
Phenyl propionic acids as PPAR delta activators
Grant 8,362,016 - Sauerberg , et al. January 29, 2
2013-01-29
Novel Compounds, Their Preparation And Use
App 20120046350 - Jeppesen; Lone ;   et al.
2012-02-23
Phenoxy Acetic Acids As Ppar Delta Activators
App 20110245244 - Sauerberg; Per ;   et al.
2011-10-06
Double-acylated Glp-1 Derivatives
App 20110166321 - GARIBAY; PATRICK WILLIAM ;   et al.
2011-07-07
Compounds, their preparation and use
Grant 7,968,723 - Havranek , et al. June 28, 2
2011-06-28
Compounds, their preparation and use
Grant 7,943,613 - Sauerberg , et al. May 17, 2
2011-05-17
Compounds that modulate PPAR activity, their preparation and use
Grant 7,943,612 - Sauerberg May 17, 2
2011-05-17
Novel compounds, their preparation and use
App 20110039841 - Polivka; Zdenek ;   et al.
2011-02-17
Dimeric dicarboxylic acid derivatives, their preparation and use
Grant 7,816,385 - Sauerberg , et al. October 19, 2
2010-10-19
Novel Compounds, Their Preparations and Use
App 20100210653 - Havranek; Miroslav ;   et al.
2010-08-19
Compounds, their preparation and use
Grant 7,709,528 - Jeppesen , et al. May 4, 2
2010-05-04
Novel compounds, their preparation and use
App 20090209588 - Havranek; Miroslav ;   et al.
2009-08-20
Novel Compounds, Their Preparation And Use
App 20090093484 - Sauerberg; Per ;   et al.
2009-04-09
Compounds That Modulate Ppar Activity, Their Preparation And Use
App 20090048257 - Sauerberg; Per
2009-02-19
Novel Compounds, Their Preparations And Use
App 20080114036 - Havranek; Miroslav ;   et al.
2008-05-15
Compounds, their preparation and use
Grant 7,220,877 - Sauerberg , et al. May 22, 2
2007-05-22
Combination therapy using a dual PPAR-.alpha./PPAR-.gamma. activator and a GLP-1 derivative for the treatment of metabolic syndrome and related diseases and disorders
Grant 7,202,213 - Mogensen , et al. April 10, 2
2007-04-10
Novel compounds, their preparation and use
App 20060287393 - Jeppesen; Lone ;   et al.
2006-12-21
Peroxisome proliferator activated receptor-active arylene acetic acid derivatives
Grant 7,129,268 - Jeppesen , et al. October 31, 2
2006-10-31
Compounds, their preparation and use
Grant 7,091,245 - Jeppesen , et al. August 15, 2
2006-08-15
Compounds, their preparation and use
Grant 7,067,530 - Jeppesen , et al. June 27, 2
2006-06-27
Compounds, their preparation and use
Grant 6,972,294 - Murray , et al. December 6, 2
2005-12-06
Novel compounds, their preparation and use
App 20050080115 - Jeppesen, Lone ;   et al.
2005-04-14
Novel compounds, their preparation and use
App 20050070583 - Jeppesen, Lone ;   et al.
2005-03-31
Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
Grant 6,869,967 - Jeppesen , et al. March 22, 2
2005-03-22
Compounds, their preparation and use
Grant 6,867,218 - Mogensen , et al. March 15, 2
2005-03-15
Novel compounds, their preparation and use
App 20040259950 - Sauerberg, Per ;   et al.
2004-12-23
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
App 20040229899 - Jeppesen, Lone ;   et al.
2004-11-18
Novel compounds, their preparation and use
App 20040143006 - Jeppesen, Lone ;   et al.
2004-07-22
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
Grant 6,723,731 - Jeppesen , et al. April 20, 2
2004-04-20
Heterocyclic compounds and their preparation and use
Grant 6,720,342 - Jeppesen , et al. April 13, 2
2004-04-13
Compounds, their preparation and use
Grant 6,703,401 - Jeppesen , et al. March 9, 2
2004-03-09
Compounds, their preparation and use
Grant 6,683,111 - Jeppesen , et al. January 27, 2
2004-01-27
Combination therapy using a dual PPAR-a/PPAR-y activator and a GLP-1 derivative for the treatment of metabolic syndrome and related diseases and disorders
App 20030199451 - Mogensen, John Patrick ;   et al.
2003-10-23
Compounds, their preparation and use
App 20030195200 - Mogensen, John Patrick ;   et al.
2003-10-16
New compounds, their preparation and use
App 20030171358 - Jeppesen, Lone ;   et al.
2003-09-11
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
Grant 6,602,901 - Jeppesen , et al. August 5, 2
2003-08-05
Novel compounds, their preparation and use
App 20030139473 - Jeppesen, Lone ;   et al.
2003-07-24
Novel compounds, their preparation and use
App 20030109560 - Jeppesen, Lone ;   et al.
2003-06-12
Novel compounds, their preparation and use
App 20030109579 - Sauerberg, Per ;   et al.
2003-06-12
Novel compounds, their preparation and use
App 20030055076 - Jeppesen, Lone ;   et al.
2003-03-20
Substituted hetero-polycyclic compounds as PPAR.alpha. and PPAR.gamma. activators
Grant 6,468,996 - Jeppesen , et al. October 22, 2
2002-10-22
New compounds, their preparation and use
App 20020128260 - Jeppesen, Lone ;   et al.
2002-09-12
Substituted hetero-polycyclic compounds as PPARalpha and PPARgamma
App 20020115657 - Jeppesen, Lone ;   et al.
2002-08-22
Heterocyclic compounds and their preparation and use
App 20020115697 - Jeppesen, Lone ;   et al.
2002-08-22
New compounds, their preparation and use
App 20020115654 - Jeppesen, Lone ;   et al.
2002-08-22
Substituted hetero-polycyclic compounds as PPARalpha and PPARgamma activators
App 20020111344 - Jeppesen, Lone ;   et al.
2002-08-15
Substituted hetero-polycyclic compounds as PPARalpha and PPARgamma activators
App 20020103188 - Jeppesen, Lone ;   et al.
2002-08-01
Compounds, their preparation and use
App 20020065267 - Jeppesen, Lone ;   et al.
2002-05-30
New compounds, their preparation and use
App 20020065268 - Jeppesen, Lone ;   et al.
2002-05-30
New compounds, their preparation and use
App 20020061880 - Jeppesen, Lone ;   et al.
2002-05-23
Compounds, their preparation and use
App 20020061876 - Jeppesen, Lone ;   et al.
2002-05-23
New compounds, their preparation and use
App 20020055502 - Jeppesen, Lone ;   et al.
2002-05-09
New compounds, their preparation and use
App 20020022656 - Sauerberg, Per ;   et al.
2002-02-21
New compounds, their preparation and use
App 20020010171 - Jeppesen, Lone ;   et al.
2002-01-24
New compounds, their preparation and use
App 20010041709 - Mogensen, John Patrick ;   et al.
2001-11-15
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
App 20010031762 - Jeppesen, Lone ;   et al.
2001-10-18
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors(PPAR)
App 20010031764 - Jeppesen, Lone ;   et al.
2001-10-18
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
App 20010031786 - Jeppesen, Lone ;   et al.
2001-10-18
New compounds, their preparation and use
App 20010029256 - Jeppesen, Lone ;   et al.
2001-10-11
Compounds, their preparation and use
Grant 6,274,608 - Sauerberg , et al. August 14, 2
2001-08-14
Heterocyclic compounds and their use
Grant 5,773,452 - Sauerberg , et al. June 30, 1
1998-06-30
Piperdine compounds and their preparation and use
Grant 5,712,297 - Sauerberg , et al. January 27, 1
1998-01-27
Heterocyclic compounds and their preparation and use
Grant 5,641,791 - Sauerberg , et al. June 24, 1
1997-06-24
Certain 1-azabicyclo[3.3.1]nonene derivatives and their pharmacological uses
Grant 5,578,602 - Sauerberg , et al. November 26, 1
1996-11-26
Certain [1,2,5-thiadiazol-4-yl]-1-azabicyclo [3.2.1]octane derivatives and their pharmaceutical uses
Grant 5,574,043 - Sauerberg , et al. November 12, 1
1996-11-12
Heterocyclic compounds and their preparation and use
Grant 5,571,826 - Sauerberg , et al. November 5, 1
1996-11-05
Heterocyclic compounds and their preparation and use
Grant 5,527,813 - Sauerberg , et al. June 18, 1
1996-06-18
Heterocyclic compounds and their preparation and use
Grant 5,418,240 - Sauerberg , et al. May 23, 1
1995-05-23
Azabicyclo substituted oxa- or thia-diazole compounds
Grant 5,414,009 - Olesen , et al. May 9, 1
1995-05-09
3-(5-isoxazolyl)-1-methyl-1,2,3,6-tetrahydropyridine useful for treating Alzheimer's disease
Grant 5,356,912 - Nielsen , et al. October 18, 1
1994-10-18
Piperidine compounds and their use
Grant 5,328,925 - Sauerberg , et al. * July 12, 1
1994-07-12
Heterocyclic compounds and use
Grant 5,328,923 - Sauerberg , et al. * July 12, 1
1994-07-12
Heterocyclic compounds and their use
Grant 5,328,924 - Sauerberg , et al. * July 12, 1
1994-07-12
Piperidine compounds and their use
Grant 5,284,859 - Sauerberg , et al. February 8, 1
1994-02-08
Piperidine compounds and use
Grant 5,264,444 - Sauerberg , et al. * November 23, 1
1993-11-23
3-substituted and optionally 1-substituted azacyclic or azabicyclic compounds, pharmaceutical compositions, thereof and their use as stimulants of cognitive functions
Grant 5,262,427 - Nielson , et al. November 16, 1
1993-11-16
Certain 3-(1,2,5-oxa- or thiadiazol-4-yl)-1-azabicyclo [2.2.2]octanes having pharmaceutical properties
Grant 5,260,314 - Sauerberg , et al. November 9, 1
1993-11-09
Piperidine compounds and their use
Grant 5,260,311 - Sauerberg , et al. * November 9, 1
1993-11-09
Piperidine compounds and their preparation and use
Grant 5,043,345 - Sauerberg , et al. August 27, 1
1991-08-27
Piperidine compounds and their preparation and use
Grant 5,041,455 - Sauerberg , et al. August 20, 1
1991-08-20
Lipophilically-substituted piperidine oxadiazolyl compounds and their use in stimulating cognitive functions (II)
Grant 4,933,353 - Jensen , et al. June 12, 1
1990-06-12
Lipophillically-substituted piperidine oxadiazolyl compounds and their use in stimulating cognitive functions
Grant 4,837,241 - Jensen , et al. June 6, 1
1989-06-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed